ASCO Genitourinary Cancers Symposium
ASCO GU 2022 Updates on Neoadjuvant Cabozantinib in Locally Advanced Non-Metastatic ccRCC: Phase 2 Study
By
ASCO Genitourinary Cancers Symposium
FEATURING
Mehmet Bilen
By
ASCO Genitourinary Cancers Symposium
FEATURING
Mehmet Bilen
Login to view comments.
Click here to Login